ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

8.81

+0.48 (5.76%)

At close: May 15, 2026, 4:00 PM EDT

8.82

+0.01 (0.11%)

After-hours: May 15, 2026, 4:22 PM EDT

5.76% (1D)

Assets	$2.35M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	n/a
Dividend (ttm)	$0.43
Dividend Yield	4.92%
Ex-Dividend Date	Mar 25, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	33,308
Open	8.52
Previous Close	8.33
Day's Range	8.52 - 8.83
52-Week Low	7.95
52-Week High	20.81
Beta	n/a
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange NASDAQ

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-199.95% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-33.44%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-35.80%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-36.98%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-37.68%
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-56.05%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 25, 2026	$0.06857	Mar 31, 2026
Dec 24, 2025	$0.10257	Dec 31, 2025
Sep 24, 2025	$0.15427	Sep 30, 2025
Jun 25, 2025	$0.10805	Jul 1, 2025
Mar 26, 2025	$0.13255	Apr 1, 2025
Dec 23, 2024	$0.20639	Dec 31, 2024

Full Dividend History

Performance

BIS had a total return of -56.06% in the past year, including dividends. Since the fund's inception, the average annual return has been -31.91%.